A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
Clinical trial NCT04844918 · COMPLETED
Trial details
- NCT number
- NCT04844918
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2023-06-24
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.